IFM Therapeutics

Showing 2 posts of 2 posts found.

novartis_outside_1

Novartis inks $1.6 billion deal with immunology biotech IFM Therapeutics

April 1, 2019
Sales and Marketing Atlas Venture, Boston, IFM Therapeutics, Novartis, pharma

Swiss firm Novartis has agreed to pay a sum of $310 million upfront to Boston inflammation specialist IFM Therapeutics, as …

original

Bristol-Myers Squibb’s $2.3 billion gamble to boost cancer pipeline

August 4, 2017
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, IFM Therapeutics, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …

Latest content